Financials

News Ideas Technicals Forecast

ELVN fundamentals

Overview Statements Statistics Dividends Earnings Revenue

The current financial position of Enliven Therapeutics, Inc.

Total assets of ELVN for Q1 24 is 342.78 M USD, 26.08% more than the previous Q4 23. And total liabilities decreased by 3.45% in Q1 24 to 25.07 M USD.

Q3 '22

Q4 '22

Q1 '23

Q2 '23

Q3 '23

Q4 '23

Q1 '24

‪0.00‬

Total assets

Total liabilities

Income statement Balance sheet Cash flow

Currency: USD

Q3 '22

Q4 '22

Q1 '23

Q2 '23

Q3 '23

Q4 '23

Q1 '24

YoY growth

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—